Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Alliance Pharma Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Alliance Pharma has a total shareholder equity of £222.9M and total debt of £102.4M, which brings its debt-to-equity ratio to 46%. Its total assets and total liabilities are £398.3M and £175.4M respectively. Alliance Pharma's EBIT is £43.6M making its interest coverage ratio 4.3. It has cash and short-term investments of £19.3M.

Anahtar bilgiler

46.0%

Borç/özkaynak oranı

UK£102.43m

Borç

Faiz karşılama oranı4.3x
NakitUK£19.27m
EşitlikUK£222.90m
Toplam yükümlülüklerUK£175.41m
Toplam varlıklarUK£398.31m

Son finansal sağlık güncellemeleri

Recent updates

Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Sep 10
Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Is Alliance Pharma (LON:APH) A Risky Investment?

Jun 21
Is Alliance Pharma (LON:APH) A Risky Investment?

Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Feb 23
Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

Nov 21
Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

May 26
We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

Mar 24
Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

Sep 30
We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

May 28
An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Mar 30
Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Dec 24
Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

Nov 19
Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: APH's short term assets (£93.3M) exceed its short term liabilities (£31.8M).

Uzun Vadeli Yükümlülükler: APH's short term assets (£93.3M) do not cover its long term liabilities (£143.6M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: APH 'nin net borç/öz sermaye oranı ( 37.3% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: APH's debt to equity ratio has increased from 35.1% to 46% over the past 5 years.

Borç Kapsamı: APH's debt is well covered by operating cash flow (29.5%).

Faiz Kapsamı: APH's interest payments on its debt are well covered by EBIT (4.3x coverage).


Bilanço


Sağlıklı şirketleri keşfedin